India's pharma exports to US surged in March amid tariff concerns

India's pharma exports saw a significant rise in March, driven by fears of impending US tariffs. Industry experts anticipate impact of potential reciprocal tariffs on India's future export strategy

India’s pharma exports to the United States (US) in March surged almost 74 per cent $1.561 billion, with this coming at a time when talks on potential US tariffs were getting louder, the data from the Pharmaceutical Exports Promotion Council (Pharmexcil) showed.

 

Export growth in March over February was around 71 per cent.

 

Speaking to Business Standard, Namit Joshi, chairman, Pharmexcil, said the situation was “dynamic” and trade, particularly with the US, had been influenced by tariff concerns.

 

The data showed in April exports to the US fell 7.27 per cent to $898.34 million as against $968.79 million in the